These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36516094)

  • 1. The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa.
    Schaffer DV
    N Engl J Med; 2022 Dec; 387(24):2279-2280. PubMed ID: 36516094
    [No Abstract]   [Full Text] [Related]  

  • 2. Overcoming obstacles for gene therapy for recessive dystrophic epidermolysis bullosa.
    Lanuti EL; Wikramanayake TC; Kirsner RS
    J Invest Dermatol; 2011 Jan; 131(1):5. PubMed ID: 21157419
    [No Abstract]   [Full Text] [Related]  

  • 3. siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.
    Pendaries V; Gasc G; Titeux M; Tonasso L; Mejía JE; Hovnanian A
    J Invest Dermatol; 2012 Jun; 132(6):1741-3. PubMed ID: 22336946
    [No Abstract]   [Full Text] [Related]  

  • 4. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
    Vanden Oever M; Twaroski K; Osborn MJ; Wagner JE; Tolar J
    Pediatr Res; 2018 Jan; 83(1-2):318-324. PubMed ID: 29593249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa.
    Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W
    Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L; Greiser U; Wang W
    Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa.
    Morgan CP; Allen DSI; Millington-Ward S; O'Dwyer GE; Palfi A; Jane Farrar G
    J Invest Dermatol; 2013 Dec; 133(12):2793-2796. PubMed ID: 23743647
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy for recessive dystrophic epidermolysis bullosa.
    Titeux M; Pendaries V; Hovnanian A
    Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.
    Wang X; Alshehri F; Manzanares D; Li Y; He Z; Qiu B; Zeng M; A S; Lara-Sáez I; Wang W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S; Barriga M; Ponakala A; Teng C; Nguyen NT; Siprashvili Z; Nazaroff J; Gorell ES; Chiou AS; Taylor L; Khuu P; Keene DR; Rieger K; Khosla RK; Furukawa LK; Lorenz HP; Marinkovich MP; Tang JY
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.
    Gaucher S; Lwin SM; Titeux M; Abdul-Wahab A; Pironon N; Izmiryan A; Miskinyte S; Ganier C; Duchatelet S; Mellerio JE; Bourrat E; McGrath JA; Hovnanian A
    Br J Dermatol; 2020 Mar; 182(3):794-797. PubMed ID: 31557321
    [No Abstract]   [Full Text] [Related]  

  • 12. Recessive Dystrophic Epidermolysis Bullosa: Advances in the Laboratory Leading to New Therapies.
    Woodley DT; Chen M
    J Invest Dermatol; 2015 Jul; 135(7):1705-1707. PubMed ID: 26066885
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
    Guide SV; Gonzalez ME; Bağcı IS; Agostini B; Chen H; Feeney G; Steimer M; Kapadia B; Sridhar K; Quesada Sanchez L; Gonzalez F; Van Ligten M; Parry TJ; Chitra S; Kammerman LA; Krishnan S; Marinkovich MP
    N Engl J Med; 2022 Dec; 387(24):2211-2219. PubMed ID: 36516090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C; Osborn MJ; Tolar J
    Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermolysis bullosa dystrophica pretibialis - Clinical snapshot and management of a rare orphan disease.
    Will LM; Reichrath J; Vogt T
    J Dtsch Dermatol Ges; 2021 Jul; 19(7):983-986. PubMed ID: 33951274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic Epidermolysis Bullosa.
    Yadav RS; Jayswal A; Shrestha S; Gupta SK; Paudel U
    JNMA J Nepal Med Assoc; 2018; 56(213):879-882. PubMed ID: 31065125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
    Takashima S; Shinkuma S; Fujita Y; Nomura T; Ujiie H; Natsuga K; Iwata H; Nakamura H; Vorobyev A; Abe R; Shimizu H
    J Invest Dermatol; 2019 Aug; 139(8):1711-1721.e4. PubMed ID: 30831133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical sucralfate cream treatment for aplasia cutis congenita with dystrophic epidermolysis bullosa: a case study.
    Yaşar Ş; Yaşar B; Cebeci F; Bayoğlu D; Nuhoğlu Ç
    J Wound Care; 2018 Nov; 27(11):768-771. PubMed ID: 30398936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recessive Dystrophic Epidermolysis Bullosa and Pregnancy.
    Boria F; Maseda R; Martín-Cameán M; De la Calle M; de Lucas R
    Actas Dermosifiliogr (Engl Ed); 2019; 110(1):50-52. PubMed ID: 29203033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.